Clinical Trials Browser

Phase 3 × Cisplatin × Genitourinary × Clear all

NCT03967977 2026-04-17

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

NCT03661320 2026-04-15

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT06524544 2026-04-15

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Phase 3 Recruiting

Carcinoma, Transitional Cell

NCT03775265 2026-04-13

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT04658862 2026-04-13

SunRISe-2

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT07097142 2026-04-08

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Phase 3 Recruiting

Urinary Bladder Neoplasms

NCT05911295 2026-04-07

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Phase 3 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06960577 2026-03-30

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Phase 3 Recruiting

Urinary Bladder Neoplasms

NCT03732677 2026-03-13

NIAGARA

Phase 3 Active not recruiting

1,063 enrolled 15 charts 3 FDA

Urinary Bladder Neoplasms

NCT03036098 2026-03-06

CheckMate901

Phase 3 Active not recruiting

1,314 enrolled 23 charts 2 FDA

Urothelial Cancer

NCT07393542 2026-03-03

A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma

Phase 3 Recruiting

Carcinoma, Transitional Cell

NCT04700124 2026-02-05

KEYNOTE-B15

Phase 3 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT03682068 2026-02-03

NILE

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT02516241 2026-01-28

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Phase 3 Active not recruiting

1,126 enrolled 52 charts

Urothelial Cancer

NCT02341989 2025-12-02

SWENOTECA-ABC

Phase 3 Active not recruiting

Recurrence, Testicular Neoplasms, Seminoma

NCT03924856 2025-08-28

KEYNOTE-866

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT04574960 2025-07-20

NAUTICAL

Phase 3 Recruiting

Urinary Bladder Neoplasms

NCT04223856 2025-06-13

EV-302

Phase 3 Active not recruiting

886 enrolled 12 charts 2 FDA

Urothelial Cancer

NCT02305654 2025-04-02

InPACT

Phase 3 Recruiting

Penile Neoplasms

NCT02807636 2025-02-24

IMvigor130

Phase 3 Completed

1,213 enrolled 35 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06364904 2025-02-21

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Phase 3 Not yet recruiting

Urinary Bladder Neoplasms

NCT00104676 2025-02-06

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Phase 3 Completed

263 enrolled 10 charts

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT04241185 2024-11-25

MK-3475-992

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT06592326 2024-09-19

9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer

Phase 3 Recruiting

Carcinoma, Transitional Cell

NCT05302284 2023-12-18

A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma

Phase 3 Recruiting

Carcinoma, Transitional Cell

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00003376 2023-06-22

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Phase 3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00003701 2023-06-15

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00053352 2021-07-13

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Phase 3 Completed

302 enrolled 9 charts

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

NCT00002566 2021-02-23

Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors

Phase 3 Completed

Testicular Germ Cell Tumor, Testicular Neoplasms

NCT04568304 2020-09-29

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Phase 3 Unknown

Carcinoma, Transitional Cell

NCT01993979 2020-05-04

POUT

Phase 3 Unknown

Transitional Cell Carcinoma of Ureter

NCT00330499 2017-07-12

Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Terminated

521 enrolled 18 charts

Urinary Bladder Neoplasms

NCT00028756 2016-08-02

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00014534 2016-07-14

Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00072215 2016-07-04

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Phase 3 Terminated

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00625664 2016-05-05

CILAB

Phase 3 Completed

Urinary Bladder Neoplasms, Neoplasms

NCT02074189 2014-02-28

Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00054626 2013-12-18

Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

Phase 3 Unknown

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

NCT00324298 2013-08-12

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Phase 3 Completed

Testicular Germ Cell Tumor, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00002596 2013-06-26

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Phase 3 Completed

Teratoma, Testicular, Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00022191 2013-06-12

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Phase 3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT01734798 2012-11-28

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

Phase 3 Completed

Locally Advanced Bladder Cancer

NCT00003941 2012-09-24

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer

Phase 3 Completed

CNSGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Brain Neoplasms, Mediastinal Neoplasms, Neoplasm Metastasis, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00237575 2012-05-23

Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms, Neoplasm Metastasis